SMA 50 společnosti Kazia Therapeutics
Jaká je hodnota metriky SMA 50 společnosti Kazia Therapeutics?
Hodnota metriky SMA 50 společnosti Kazia Therapeutics Limited je AUD$0 -4.69%
Jaká je definice metriky SMA 50?
SMA 50 je průměrná cena akcií z posledních 50 dnů vypočítaná jako nevážený průměr předchozích 50 závěrečných cen.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 společností v sektoru Health Care sektor na ASX ve srovnání se společností Kazia Therapeutics
Čemu se věnuje společnost Kazia Therapeutics?
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.
Firmy s metrikou sma 50 podobnou společnosti Kazia Therapeutics
- Hodnota metriky SMA 50 společnosti Corus Entertainment je $0 +30.56%
- Hodnota metriky SMA 50 společnosti Pancontinental Resources je $0 -19.20%
- Hodnota metriky SMA 50 společnosti Vizsla Copper Corp je CAD$0 -39.13%
- Hodnota metriky SMA 50 společnosti China Technology Solar Power je HKD$0 +2.91%
- Hodnota metriky SMA 50 společnosti K9 Gold je $0 -11.41%
- Hodnota metriky SMA 50 společnosti Brainhole Technology je HKD$0 -3.29%
- Hodnota metriky SMA 50 společnosti Kazia Therapeutics je AUD$0 -4.69%
- Hodnota metriky SMA 50 společnosti Panoro Minerals je $0 +44.14%
- Hodnota metriky SMA 50 společnosti Clontarf plc je GBX0 -26.08%
- Hodnota metriky SMA 50 společnosti Tuktu Resources Ltd je CAD$0 +6.81%
- Hodnota metriky SMA 50 společnosti Rhyolite Resources je CAD$0 -4.84%
- Hodnota metriky SMA 50 společnosti Capital Environment je HKD$0 -15.40%
- Hodnota metriky SMA 50 společnosti Vectus Biosystems je AUD$0 -5.30%